Budoff, Matthew J.

Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial

Knowler, W. C., Doherty, L., Edelstein, S. L., Bennett, P. H., Dabelea, D., Hoskin, M., Kahn, S. E., Kalyani, R. R., Kim, C., Pi-Sunyer, F. X., et al. (2025) · The Lancet Diabetes & Endocrinology

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 39

Benefit of icosapent ethyl on coronary physiology assessed by computed tomography angiography fractional flow reserve: EVAPORATE-FFRCT

Rabbat, M. G., Lakshmanan, S., Benjamin, M. M., Doros, G., Kinninger, A., Budoff, M. J., & Bhatt, D. L. (2023) · European Heart Journal - Cardiovascular Imaging

Cardiac Imaging and DiagnosticsCoronary Interventions and Diagnostics

Cited by 34

Coronary Artery Calcium Staging to Guide Preventive Interventions

Maron, D. J., Budoff, M. J., Sky, J. C., Bommer, W. J., Epstein, S. D., Fisher, D. A., Stock, E. O., Taylor, A. J., Wong, N. D., & DeMaria, A. N. (2024) · JACC: Advances

Cardiac Imaging and DiagnosticsLipoproteins and Cardiovascular Health

Cited by 32

Coronary atherosclerosis scoring with semiquantitative CCTA risk scores for prediction of major adverse cardiac events: propensity score-based analysis of diabetic and non-diabetic patients

van den Hoogen, I. J., van Rosendael, A. R., Lin, F. Y., Lu, Y., Dimitriu-Leen, A. C., Smit, J. M., Scholte, A. J. H. A., Achenbach, S., Al-Mallah, M. H., Andreini, D., et al. (2020) · Journal of Cardiovascular Computed Tomography

Cardiac Imaging and DiagnosticsCoronary Interventions and Diagnostics

Cited by 31

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 29

Use of coronary artery calcium testing to improve coronary heart disease risk assessment in a lung cancer screening population: the Multi-Ethnic Study of Atherosclerosis (MESA)

Garg, P. K., Jorgensen, N. W., McClelland, R. L., Leigh, J. A., Greenland, P., Blaha, M. J., Yoon, A. J., Wong, N. D., Yeboah, J., & Budoff, M. J. (2018) · Journal of Cardiovascular Computed Tomography

Cardiac Imaging and DiagnosticsHealth Promotion and Cardiovascular Prevention

Cited by 26

Traditional cardiovascular disease risk factors associated with one-year all-cause mortality among those with coronary artery calcium scores ≥400

Al Rifai, M., McEvoy, J. W., Nasir, K., Rumberger, J., Feldman, D., Budoff, M. J., & Blaha, M. J. (2015) · Atherosclerosis

Cardiac Imaging and DiagnosticsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 12

EPA Versus Mixed EPA/DHA Plus Statin for Coronary Atherosclerosis

Sheppard, J. P., Lakshmanan, S., Dahal, S., Roy, S. K., Bhatt, D. L., Budoff, M. J., & Nelson, J. R. (2022) · JACC: Cardiovascular Imaging

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 7

Effects of Eicosapentaenoic Acid vs Eicosapentaenoic/Docosahexaenoic Acids on Cardiovascular Mortality

Sheppard, J. P., Palatnic, L., Lakshmanan, S., Drago, T., Bhogal, J., Roy, S. K., Bhatt, D. L., Budoff, M. J., & Nelson, J. R. (2025) · JACC: Advances

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 3

Agatston-2.0: A next-generation AI-based coronary calcium quantification approach to improve risk stratification among individuals with zero Agatston scores – Part I

Naghavi, M., Azimi, A., Atlas, K., Reeves, A. P., Zhang, C., Mirjalili, S. R., Mozafarybazargany, M., Jolfayi, A. G., Hashemi, A., Atlas, T., et al. (2026) · American Journal of Preventive Cardiology

Cardiac Imaging and DiagnosticsArtificial Intelligence in Healthcare and Education

Cited by 2

EFFECTS OF PURIFIED EICOSAPENTAENOIC ACID VERSUS MIXED EICOSAPENTAENOIC/DOCOSAHEXAENOIC ACID ON CARDIOVASCULAR MORTALITY: META-ANALYSIS OF RANDOMIZED CLINICAL ENDPOINT TRIALS

Sheppard, J. P., Palatnic, L., Lakshmanan, S., Drago, T., Bhogal, J., Roy, S., Bhatt, D. L., Budoff, M. J., & Nelson, J. R. (2024) · Journal of the American College of Cardiology

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 2

Abstract 10905: Relationship of Eicosapentaenoic Acid and Docosahexaenoic Acid Dosage to Plaque Progression in Patients With Coronary Atherosclerosis Receiving Statin and Polyunsaturated Fatty Acid Therapy

Sheppard, J. P., Lakshmanan, S., Roy, S. K., Bhatt, D. L., Budoff, M. J., & Nelson, J. R. (2022) · Circulation

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 1

Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals

Abuknesha, N. R., O’Keefe, J. H., Qian, F., Tintle, N. L., Lin, Y., Sun, Y., Qian, H.-Z., Aisen, P. S., Albert, C. M., Aronson, W. J., et al. (2026) · Circulation: Arrhythmia and Electrophysiology

Fatty Acid Research and HealthAtrial Fibrillation Management and Outcomes

Cited by 1